Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus

ConclusionGiven the wide use of JAKi in clinical practice, it is crucial to establish a specific follow-up for each patient ’s phenotype in order to achieve the best possible clinical outcome and minimize potential adverse events.
Source: Dermatology and Therapy - Category: Dermatology Source Type: research